Xeris Biopharma Holdings, Inc. (FRA:2B30)

Xeris Biopharma Holdings Revenue

Xeris Biopharma Holdings had revenue of $74.38M USD in the quarter ending September 30, 2025, with 37.06% growth. This brings the company's revenue in the last twelve months to $266.14M, up 42.05% year-over-year. In the year 2024, Xeris Biopharma Holdings had annual revenue of $203.07M with 23.89% growth.

• Revenue (ttm): $266.14M
• Revenue Growth: +42.05%
• P/S Ratio: 4.58
• Revenue / Employee: $675.47K
• Employees: 394
• Market Cap: 1.04B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	203.07M	39.16M	23.89%
Dec 31, 2023	163.91M	53.67M	48.68%
Dec 31, 2022	110.25M	60.66M	122.32%
Dec 31, 2021	49.59M	29.16M	142.67%
Dec 31, 2020	20.44M	17.71M	650.73%
Dec 31, 2019	2.72M	299.00K	12.34%
Dec 31, 2018	2.42M	867.00K	55.72%
Dec 31, 2017	1.56M	481.00K	44.74%
Dec 31, 2016	1.08M	-	-